RELAPSED/REFRACTORY SMALL CELL LUNG CANCER
Clinical trials for RELAPSED/REFRACTORY SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets tough lung cancer in early trial
Disease control Recruiting nowThis study tests an experimental drug called BMS-986525, given alone or with the immunotherapy nivolumab (Opdivo), in 240 people whose small cell lung cancer has returned or stopped responding to standard platinum-based chemotherapy. The main goals are to check safety and tolerab…
Matched conditions: RELAPSED/REFRACTORY SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Engineered immune cells take on tough lung cancer in first human trial
Disease control Recruiting nowThis early-phase study tests a new treatment called GC511B for adults with small cell lung cancer that has come back or stopped responding to standard therapy. The treatment uses the patient's own immune cells, which are modified in a lab to better recognize and attack cancer cel…
Matched conditions: RELAPSED/REFRACTORY SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC